Central serous chorioretinopathy is an idiopathic condition characterized by the development of a serous detachment of the sensory retina especially in healthy men between 25 and 55 years of age. Observation of the patients at least for three months for spontaneous recovery in unilateral central serous chorioretinopathy is recommended. Conventional treatment modalities include laser photocoagulation and photodynamic therapy but these treatments can cause permanent damage to the retinal pigment epithelium or choriocapillary. Recently intravitreal anti-vascular endothelial growth factor agents have been used to ameliorate this condition but their results are contraversial. Herein we present a succesful treatment of a patient with chronic central serous chorioretinopathy with a single dose of intravitreal ranibizumab injection.
Kan, E., & Eskı Yucel, Ö. (2016). Recovery of chronic central serous chorioretinopathy with a single dose of intravitreal ranibizumab injection: A case report. Journal of Experimental and Clinical Medicine, 32(4). https://doi.org/10.5835/jecm.omu.32.04.009
AMA
Kan E, Eskı Yucel Ö. Recovery of chronic central serous chorioretinopathy with a single dose of intravitreal ranibizumab injection: A case report. J. Exp. Clin. Med. January 2016;32(4). doi:10.5835/jecm.omu.32.04.009
Chicago
Kan, Emrah, and Özlem Eskı Yucel. “Recovery of Chronic Central Serous Chorioretinopathy With a Single Dose of Intravitreal Ranibizumab Injection: A Case Report”. Journal of Experimental and Clinical Medicine 32, no. 4 (January 2016). https://doi.org/10.5835/jecm.omu.32.04.009.
EndNote
Kan E, Eskı Yucel Ö (January 1, 2016) Recovery of chronic central serous chorioretinopathy with a single dose of intravitreal ranibizumab injection: A case report. Journal of Experimental and Clinical Medicine 32 4
IEEE
E. Kan and Ö. Eskı Yucel, “Recovery of chronic central serous chorioretinopathy with a single dose of intravitreal ranibizumab injection: A case report”, J. Exp. Clin. Med., vol. 32, no. 4, 2016, doi: 10.5835/jecm.omu.32.04.009.
ISNAD
Kan, Emrah - Eskı Yucel, Özlem. “Recovery of Chronic Central Serous Chorioretinopathy With a Single Dose of Intravitreal Ranibizumab Injection: A Case Report”. Journal of Experimental and Clinical Medicine 32/4 (January 2016). https://doi.org/10.5835/jecm.omu.32.04.009.
JAMA
Kan E, Eskı Yucel Ö. Recovery of chronic central serous chorioretinopathy with a single dose of intravitreal ranibizumab injection: A case report. J. Exp. Clin. Med. 2016;32. doi:10.5835/jecm.omu.32.04.009.
MLA
Kan, Emrah and Özlem Eskı Yucel. “Recovery of Chronic Central Serous Chorioretinopathy With a Single Dose of Intravitreal Ranibizumab Injection: A Case Report”. Journal of Experimental and Clinical Medicine, vol. 32, no. 4, 2016, doi:10.5835/jecm.omu.32.04.009.
Vancouver
Kan E, Eskı Yucel Ö. Recovery of chronic central serous chorioretinopathy with a single dose of intravitreal ranibizumab injection: A case report. J. Exp. Clin. Med. 2016;32(4).
